RecruitingNot ApplicableNCT06297265

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

Feasibility and Effects of Manual Lymphatic Drainage (MLD) Breast Massage in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy


Sponsor

University of Southern California

Enrollment

50 participants

Start Date

May 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This phase II trial evaluates manual lymphatic drainage breast massage for reducing treatment-related side effects in women undergoing radiation therapy after breast conserving surgery for breast cancer that has not spread to other parts of the body (localized). Breast conserving surgery can be an effective treatment option for early stage breast cancer, but it can also be associated with side effects including fluid collection in tissues/swelling (lymphedema), pain, reduced quality of life, and poorer body image. Manual lymphatic drainage is a gentle massage technique used to reduce swelling. It may be a safe and effective way to reduce treatment-related side effects in women receiving radiation therapy after surgery for localized breast cancer.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether manual lymphatic drainage breast massage — a gentle hands-on technique — can help reduce swelling, pain, and other side effects for women who had a lumpectomy and are undergoing whole breast radiation therapy. **You may be eligible if...** - You are a woman (18 or older) with early-stage breast cancer who had a lumpectomy - You will be receiving whole breast radiation therapy (standard or moderately hypofractionated) - You can read and understand English or Spanish **You may NOT be eligible if...** - You have a chronic inflammatory condition such as scleroderma, lupus, or rheumatoid arthritis - You have uncontrolled illness such as active infection, heart failure, or psychiatric illness that would affect your participation - You are receiving partial breast radiation or ultra-short radiation schedules - You cannot provide written consent in English or Spanish Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLymphedema Management

Undergo MLD breast massage

OTHERQuestionnaire Administration

Ancillary studies

RADIATIONAdjuvant breast radiation therapy

Using standard 3D conformal or intensity modulated techniques, patients will receive standard fractionation or moderate hypofractionation radiation therapy. The radiation treatment will last for 3 to 6 weeks, with the length of treatment depending on patient's specific clinical situation.


Locations(1)

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06297265


Related Trials